Migraine Prophylaxis with Topiramate

Initiation and Dosing

The American Academy of Neurology recommends initiating topiramate at 25 mg daily and gradually titrating to a target dose of 100 mg/day for migraine prophylaxis, as this dose provides the optimal balance of efficacy and tolerability for most patients 1

Women of childbearing potential must use effective contraception as topiramate can reduce the efficacy of hormonal contraceptives and has teratogenic risks, according to the American College of Obstetricians and Gynecologists 1
Patients with comorbid conditions, such as obesity or binge eating disorder, may benefit from topiramate, as suggested by the American Heart Association 2
Patients with mood disorders should be monitored for depression and cognitive slowing, as recommended by the American Psychiatric Association 1

Common adverse effects of topiramate include paresthesia, cognitive effects, weight loss, fatigue, taste alterations, and nausea, with paresthesia occurring in 35-51% of patients 1

Topiramate may increase the risk of kidney stones due to carbonic anhydrase inhibition, and patients should ensure adequate hydration, as advised by the National Kidney Foundation 1

A minimum 8-week trial at target dose is recommended to assess efficacy, and treatment typically continues for 6-12 months before considering gradual withdrawal, as suggested by the American Academy of Neurology 1